BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lazzarotto-da-Silva G, Scaffaro LA, Farenzena M, Prediger L, Silva RK, Feier FH, Grezzana-Filho TJM, Rodrigues PD, de Araujo A, Alvares-da-Silva MR, Marchiori RC, Kruel CRP, Chedid MF. Transarterial embolization is an acceptable bridging therapy to hepatocellular carcinoma prior to liver transplantation. World J Transplant 2024; 14(2): 90571 [PMID: 38947974 DOI: 10.5500/wjt.v14.i2.90571]
URL: https://www.wjgnet.com/2220-3230/full/v14/i2/90571.htm
Number Citing Articles
1
Bruna De Fina, Felipe Nasser, Breno Boueri Affonso, Francisco Leonardo Galastri, Leonardo Guedes Moreira Valle, Marcela Juliano Silva Cunha, Guilherme Cayres Mariotti, Ary Serpa, Rodrigo Gobbo Garcia, Nelson Wolosker. Comparing radiological response to radiofrequency ablation, percutaneous ethanol injection, and transarterial chemoembolization in patients with hepatocellular carcinoma on the waiting list for liver transplanteinstein (São Paulo) 2025; 23 doi: 10.31744/einstein_journal/2025AO1315
2
Jeraun Dolphin, Juan Zubillaga, Qazi Muhammad Jamal, Afrah Fathima Karimbanakkal Edakkattu, Bhavana Balakrishnan, Aarati Sapkota, Anum Naimat, Aye Nyein, Confidence Obianuju Okorie, Ahmad Mahmood, Aabind S Dev. Optimizing Transarterial Chemoembolization in Hepatocellular Carcinoma: Current Strategies, Innovations, and Future DirectionsCureus 2025;  doi: 10.7759/cureus.95128